# LETROZOLE

NDC: 50268-476
Generic name: LETROZOLE
Labeler / Manufacturer: AvPAK
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20191002

FDA application: ANDA200161

## Active ingredients

- LETROZOLE: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50268-476"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50268-476
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93f317f1-96d1-498e-e053-2995a90ac60d